{"title":"Case report: Severe arrhythmogenic cardiomyopathy in a young girl with compound heterozygous <i>DSG2</i> and <i>MYBPC3</i> variants with a 6-year follow-up.","authors":"Ryotaro Hashizume, Hiroshi Imai, Hiroyuki Ohashi, Hirofumi Sawada, Noriko Yodoya, Ryuji Okamoto, Kaoru Dohi, Chika Kasai, Takahito Kitajima, Takumi Fujiwara, Ikuyo Mochiki, Kaname Nakatani, Sachiko Wakita, Seiko Ohno, Koichi Kato, Yoshinaga Okugawa, Yoshihide Mitani, Masahiro Hirayama","doi":"10.3389/fgene.2025.1545561","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disorder characterized by progressive fibrofatty replacement of the myocardium. In the Japanese population, variants of the desmoglein-2 (<i>DSG2</i>) gene are a major cause of ACM, typically following an autosomal recessive inheritance pattern. Myosin-binding protein C (<i>MYBPC3</i>) variants are primarily associated with hypertrophic cardiomyopathy (HCM). Here, we report a severe pediatric case of ACM associated with compound heterozygous <i>DSG2</i> and <i>MYBPC3</i> variants.</p><p><strong>Case presentation: </strong>A 6-year-old asymptomatic girl was diagnosed with ACM based on abnormal electrocardiogram findings, including epsilon waves, and T-wave inversions in leads V<sub>1-6</sub> and III. Echocardiography revealed right ventricular (RV) dilatation (RV outflow tract diameter/body surface area: 22.9 mm/m<sup>2</sup>) and reduced RV function (fractional area change: 18.0%). Cardiac magnetic resonance imaging confirmed RV dysfunction (ejection fraction [EF]: 9.7%) and left ventricular (LV) involvement (EF: 48.9%). Genetic testing identified compound heterozygous <i>DSG2</i> variants (p.Arg119* and p. Arg292Cys) and an <i>MYBPC3</i> variant (p.Arg820Gln). The patient remained asymptomatic until age 10.5 years, when she developed heart failure requiring hospitalization. Imaging revealed severe biventricular dilatation (LV end-diastolic volume index: 149.5 mL/m<sup>2</sup>; RV end-diastolic volume index: 255.9 mL/m<sup>2</sup>) and biventricular dysfunction (LVEF: 9.5%; RVEF: 9.7%). Despite medical management, the patient's condition progressively worsened, and she was deemed eligible for heart transplantation.</p><p><strong>Discussion: </strong>This case illustrates the potential for severe pediatric ACM associated with compound heterozygous <i>DSG2</i> variants and a <i>MYBPC3</i> variant. The <i>DSG2</i> variants likely played a primary role disease pathogenesis, while the <i>MYBPC3</i> variant may have exacerbated the phenotype. The coexistence of desmosomal and sarcomeric gene variants is rare in cardiomyopathies, making genotype-phenotype correlations complex. Further research is needed to elucidate the interplay between these genetic factors.</p><p><strong>Conclusion: </strong>This case underscores the genetic heterogeneity and phenotypic variability in inherited cardiomyopathies. It emphasizes the importance of comprehensive genetic testing and close monitoring of affected individuals and their families.</p>","PeriodicalId":12750,"journal":{"name":"Frontiers in Genetics","volume":"16 ","pages":"1545561"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11922858/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fgene.2025.1545561","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disorder characterized by progressive fibrofatty replacement of the myocardium. In the Japanese population, variants of the desmoglein-2 (DSG2) gene are a major cause of ACM, typically following an autosomal recessive inheritance pattern. Myosin-binding protein C (MYBPC3) variants are primarily associated with hypertrophic cardiomyopathy (HCM). Here, we report a severe pediatric case of ACM associated with compound heterozygous DSG2 and MYBPC3 variants.
Case presentation: A 6-year-old asymptomatic girl was diagnosed with ACM based on abnormal electrocardiogram findings, including epsilon waves, and T-wave inversions in leads V1-6 and III. Echocardiography revealed right ventricular (RV) dilatation (RV outflow tract diameter/body surface area: 22.9 mm/m2) and reduced RV function (fractional area change: 18.0%). Cardiac magnetic resonance imaging confirmed RV dysfunction (ejection fraction [EF]: 9.7%) and left ventricular (LV) involvement (EF: 48.9%). Genetic testing identified compound heterozygous DSG2 variants (p.Arg119* and p. Arg292Cys) and an MYBPC3 variant (p.Arg820Gln). The patient remained asymptomatic until age 10.5 years, when she developed heart failure requiring hospitalization. Imaging revealed severe biventricular dilatation (LV end-diastolic volume index: 149.5 mL/m2; RV end-diastolic volume index: 255.9 mL/m2) and biventricular dysfunction (LVEF: 9.5%; RVEF: 9.7%). Despite medical management, the patient's condition progressively worsened, and she was deemed eligible for heart transplantation.
Discussion: This case illustrates the potential for severe pediatric ACM associated with compound heterozygous DSG2 variants and a MYBPC3 variant. The DSG2 variants likely played a primary role disease pathogenesis, while the MYBPC3 variant may have exacerbated the phenotype. The coexistence of desmosomal and sarcomeric gene variants is rare in cardiomyopathies, making genotype-phenotype correlations complex. Further research is needed to elucidate the interplay between these genetic factors.
Conclusion: This case underscores the genetic heterogeneity and phenotypic variability in inherited cardiomyopathies. It emphasizes the importance of comprehensive genetic testing and close monitoring of affected individuals and their families.
Frontiers in GeneticsBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
5.50
自引率
8.10%
发文量
3491
审稿时长
14 weeks
期刊介绍:
Frontiers in Genetics publishes rigorously peer-reviewed research on genes and genomes relating to all the domains of life, from humans to plants to livestock and other model organisms. Led by an outstanding Editorial Board of the world’s leading experts, this multidisciplinary, open-access journal is at the forefront of communicating cutting-edge research to researchers, academics, clinicians, policy makers and the public.
The study of inheritance and the impact of the genome on various biological processes is well documented. However, the majority of discoveries are still to come. A new era is seeing major developments in the function and variability of the genome, the use of genetic and genomic tools and the analysis of the genetic basis of various biological phenomena.